3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
11
Terminated
2
Unknown
1
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Conditions
Neoplasms
6
Depression
4
Uterine Cervical Neoplasms
2
Urinary Bladder Neoplasms
2
Triple Negative Breast Neoplasms
2
Thyroid Neoplasms
2
Prostatic Neoplasms
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Mantle-Cell
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, Follicular
2
Lymphoma
2
Head and Neck Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Burkitt Lymphoma
2
Anxiety Disorders
2
Urologic Diseases
1
Treatment Adherence and Compliance
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Smoking Cessation
1
Sarcoma
1
Radiation Fibrosis Syndrome
1
Pyloric Stenosis, Hypertrophic
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Postoperative Hemorrhage
1
Peripheral Lung Tumor
1
Patient Acceptance of Health Care
1
Obesity
1
Neoplasm Metastasis
1
Interventions
Dexamethasone
87
daratumumab
49
Lenalidomide
49
pomalidomide
33
Bortezomib
32
Cyclophosphamide
31
carfilzomib
25
Calcium Dobesilate
21
talquetamab
19
fludarabine
18
isatuximab
16
iberdomide
16
Magnetic Resonance Spectroscopy
16
Specimen Handling
15
Biopsy
14
selinexor
12
Melphalan
11
belantamab mafodotin
10
dexamethasone acetate
9
dexamethasone 21-phosphate
8
elotuzumab
7
auricularum
7
venetoclax
6
tocilizumab
5
fludarabine phosphate
5
X-Rays
5
Blood Specimen Collection
5
ruxolitinib
4
Methylprednisolone
4
Injections
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Multiple Myeloma
×
Therapeutics
×
Clear all
NCT05444348
2025-07-29
ACT
Rigshospitalet, Denmark
Phase NA
Recruiting
920 enrolled